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Background: Over-reliance on opioids in 
the perioperative period has contributed to 
the opioid epidemic and new non-opioid 
strategies for multi-modal analgesia are 
being analyzed and implemented with 
anesthesiologists playing a vital role. Data 
regarding the pattern of opioid use intra-
operatively is scarce. This study evaluates 
the trend of intraoperative opioid analgesic 
use at our institution from 2014 to 2018 
among patients undergoing laparoscopic 
cholecystectomy.
Methods: We analyzed a retrospective cohort 
of 2,554 patients without opioid dependence, 
liver, or renal failure who were administered 
opioids intraoperatively. Doses of each opioid 
were converted into morphine milligram 
equivalents (MMEs). Data were analyzed via 
univariate and multivariate linear regression 
models including surgery date, age, BMI, 
length of surgery, gender, race, and procedure.
Results: Fentanyl was the most commonly 
prescribed opioid medication intraoperatively, 
and it was typically prescribed alone. There 
was a continuous decrease in intraoperative 
MMEs from 2014 to 2018. Sub-analyses 
among patients who were prescribed fentanyl 
alone or fentanyl and hydromorphone 
together indicated that the use of fentanyl 
and hydromorphone decreased concurrently 
during the study period.
Conclusions: Our study shows a trend 
of decreasing opioid administration 
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linked to the opioid epidemic and efforts 
to control opioid administration. However, 
this study reports isolated trends in opioid 
administration during the intraoperative 
period and does not quantify other analgesic 
modality utilization. Further studies 
comparing intra-operative opioid and non-
opioid analgesic use, and related patients’ pain 
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of alternative methods. 
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Background: To evaluate the role of 
accelerated fractionated salvage radiation 
therapy (SRT) in patients with diffuse large 
B-cell lymphoma (DLBCL) refractory to 
salvage chemotherapy in preparation for high 
dose chemotherapy (HDT) and autologous 
stem cell transplant (ASCT). Relapsed/
primary refractory patients who are also 
salvage chemotherapy refractory are usually 
not considered eligible for HDT and ASCT. 
Conventional and accelerated fractionated 
salvage radiation therapy was used with 
the goal of making salvage chemotherapy 
refractory patients eligible for HDT and 
ASCT. Patients receiving two different 
radiation therapy fractionation schedules were 
compared.
Methods: We reviewed the medical records 
of 54 consecutive patients at one institution 
with DLBCL who were refractory to salvage 
chemotherapy and underwent salvage 
radiation therapy (SRT) from 2000-2019. 
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fractionated SRT (most commonly 3600 cGy 
in 20 twice daily 180 cGy fractions) and 19 
patients underwent conventional fractionated 
SRT (most commonly 3600 cGy in 20 daily 
180 cGy fractions). Patients were excluded 
if they had a complete response to salvage 
chemotherapy or the SRT fraction size <150 
cGy.
Results: We evaluated 35 males (65%) and 
19 females (35%) with a median age of 59 
(range: 24-81) at the time of SRT. Thirty 
patients (56%) had primary chemotherapy 
refractory DLBCL having never achieved a 
remission and were also refractory to salvage 
chemotherapy, while 24 patients (44%) 
were refractory to salvage chemotherapy 
following relapse. All patients were found 
to have progressive disease in response to 
salvage chemotherapy. Thirty-seven patients 
(69%) underwent high dose chemotherapy 
and proceeded to HDT and ASCT within 
180 days of radiation therapy. Accelerated 
fractionation compared to conventional 
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improvement in complete response (CR) rate 
(80% vs 26%, p<0.001), 1-year disease free 
survival (54% vs 26%, p<0.001), and 1-year 
overall survival (61% vs 39%, p=0.018). 
The rate of patients undergoing ASCT was 
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undergoing accelerated fractionation (73% vs 
60%, p=0.14).
Conclusion: In patients with DLBCL who are 
refractory to salvage chemotherapy, the use 
of salvage radiation therapy was associated 
with a high rate of conversion to ASCT 
eligibility in a group of patients that are 
frequently ineligible for ASCT. Additionally, 
the use of accelerated fractionation compared 
to conventional fractionation SRT was 
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rate, PFS, and OS. 
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